Data updated: May 26, 2026
MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4 (magnesium chloride)
Cardiovascular
Approved 2022-06-08
1
Indication
--
Phase 3 Trials
3
Years on Market
Details
- Status
- Prescription
- First Approved
- 2022-06-08
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
Companies
Active Ingredient: MAGNESIUM CHLORIDE , POTASSIUM CHLORIDE , SODIUM ACETATE , SODIUM CHLORIDE , SODIUM GLUCONATE
Website: ↗
MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4 Approval History
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
1 FDA actions from 2022 to 2022
What MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4 Treats
1 FDA approvalsOriginally approved for its first indication in 2022 .
- Other (1)
Other
(1 approval)- • Approved indication (Jun 2022)Letter
📋
Clinical Trial Registry
2 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT05067270 results posted | 18278 I8B-MC-ITTC, 2021-001987-18 | Ph 1 | completed | A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus |
| NCT00933868 | RM-R001 | Ph 2, Ph 3 | completed | Magnesium Chloride Versus Placebo in Patients Who Have Had a Stroke |
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
|
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4 FDA Label Details
Track MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4 with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.